Showing results (91-100 of 289) with videos related to
Sort By:
Pageof 29
JMIR Research Protocols|February 17, 2017
VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB TrialsVal Gebski, Emma Gibbs, Mihir Gandhi, et al.Trials|December 19, 2025
When randomisation goes horribly wrong: examples of major failures of randomisation and strategies to avoid themLisa N Yelland, Kylie M Lange, Sabine Braat, et al.Transplantation|March 19, 2024
Cost-effectiveness of Accepting Kidneys From Deceased Donors With Common Cancers-A Modeling StudyKaran K Shah, James A Hedley, Kristy P Robledo, et al.Plos One|April 28, 2015
Oil and gas wells and pipelines on U.S. wildlife refuges: challenges for managersPedro Ramirez, Sherri Baker MosleyJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2016
Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer-A Meta-AnalysisChee Khoon Lee, Johnathan Man, Sally Lord, et al.Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|October 14, 2019
Tumor depth of invasion versus tumor thickness in guiding regional nodal treatment in early oral tongue squamous cell carcinomaBrendan Liu, Rajith Amaratunga, Michael Veness, et al.ANZ Journal of Surgery|June 4, 2005
Merkel cell carcinoma: improved outcome with adjuvant radiotherapyMichael J Veness, Lakmalie Perera, Junie McCourt, et al.Journal of Minimally Invasive Gynecology|August 30, 2008
A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancerAndreas Obermair, Val Gebski, Michael Frumovitz, et al.Head & Neck|November 24, 2011
Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapyJeffrey T Wang, Carsten E Palme, Gary J Morgan, et al.The Oncologist|July 24, 2025
Under the radar-frequency, timing, duration and trajectory of lower grade adverse events in clinical trials of anti-cancer therapiesKatherine E Francis, Sarah J Lord, Sandy Simon, et al.Pageof 29